LawrenceWElmerMD

Movement Disorder

Professor of Neurology Director, The Center for Neurological Health Director, Parkinson's Disease and Movement Disorders Program University of Toledo College of Medicine

Join to view full profile

Dr. Elmer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Elmer's full profile

Already have an account?

Office
2130 W Central Ave
Ste 201
Toledo, OH 43606
Phone+1 419-291-3900

Fax+1 419-479-6055

Education & Training

University of MichiganResidency, Neurology, 1989 - 1992
University of South DakotaInternship, Internal Medicine, 1988 - 1989
University of Florida College of MedicineClass of 1987

Certifications & Licensure

OH State Medical License 1998 - 2025
MI State Medical License 1989 - 2014
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Impact of Switching to Continuous Release Dopamine Agonists Start of enrollment: 2007 Jan 01
Completed
Phase 3
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation Start of enrollment: 2013 Sep 01
Terminated
Phase 2
Fixed-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2019 Dec 13
Active, not recruiting
Phase 3
Roles: Contact
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations Start of enrollment: 2020 Oct 27
Completed
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

26 citations
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
Kelly E. Lyons, Joseph H. Friedman, Neal Hermanowicz, Stuart Isaacson, Robert A. Hauser
Clinical Neuropharmacology. 2010-01-01
6157 citations
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
Marcy E. MacDonald, Christine Ambrose, Mabel P. Duyao, Richard H. Myers, Carol Lin
Cell. 1993-03-26
302 citations
Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues.
Theresa V. Strong, Danilo A. Tagle, John Valdes, Lawrence W. Elmer, Karina Boehm
Nature Genetics. 1993-11-01

Press Mentions

Novel PD Drug Tops Pramipexole ER with Fewer Side EffectsApril 27th, 2023
Pharma Two B to Present Additional Positive Results from P2B001 Phase 3 Trial at 2023 American Academy of Neurology Annual MeetingApril 23rd, 2023
Toledo Neurologist Offers Life-Changing Care for Parksinson's PatientsApril 13th, 2019
Join now to see all